[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334301-105":59,"doc-detail-334301-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","d-loop-mutations-in-mitochondrial-dna-are-a-risk-factor-for-chemotherapy-resistance-in-esophageal-cancer","D-loop mutations in mitochondrial DNA are a risk factor for chemotherapy resistance in esophageal cancer","","Esophageal cancer remains difficult to treat due to acquired chemotherapy resistance. Mitochondrial DNA (mtDNA) accumulates mutations more readily than nuclear DNA and can disrupt cellular energy production and function. This study identifies mtDNA mutations induced after chemotherapy using next-generation sequencing in esophageal cancer cell lines and patient samples, comparing pre- and post-therapy states. Results show increased mutations after chemotherapy, especially in the D-loop region, and D-loop segment HVS1 mutations correlate with reduced mtDNA copy number, poorer chemotherapy response, and worse five-year survival.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/d-loop-mutations-in-mitochondrial-dna-are-a-risk-factor-for-chemotherapy-resistance-in-esophageal-cancer/334301/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/d-loop-mutations-in-mitochondrial-dna-are-a-risk-factor-for-chemotherapy-resistance-in-esophageal-cancer/334301.png","ImageObject",300,407,{"name":92,"@type":93},"Theodora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main research question of the study?","Question",{"text":112,"@type":113},"The study investigates whether chemotherapy induces mtDNA mutations in esophageal cancer and whether these changes relate to chemotherapy resistance and clinicopathological factors.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were mtDNA mutations assessed?",{"text":117,"@type":113},"mtDNA mutations were analyzed in esophageal cancer cell lines and patient samples using next-generation sequencing, including comparison of mutations before and after chemotherapy.",{"name":119,"@type":110,"acceptedAnswer":120},"Which mtDNA region showed the strongest association with resistance-related outcomes?",{"text":121,"@type":113},"Mutations increased after chemotherapy, particularly in the D-loop region, and HVS1 D-loop segment mutations were linked to lower mtDNA copy number, poorer response, and decreased five-year survival.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334301,1790221420,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},687197207919,"https://ap-avatar.wpscdn.com/avatar/a000253d6f5f7c60be?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779446848396160552","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nD-loop mutations in mitochondrial DNA are a risk factor for chemotherapy resistance in esophageal cancer  \nTakashi Harino1, Koji Tanaka1􀀍, Daisuke Motooka2, Yasunori Masuike1, Tsuyoshi Takahashi1, Kotaro Yamashita1, Takuro Saito1, Kazuyoshi Yamamoto1, Tomoki Makino1,  \nYukinori Kurokawa1, Kiyokazu Nakajima1, Hidetoshi Eguchi1 & Yuichiro Doki1  \nEsophageal cancer is a highly aggressive disease, and acquired resistance to chemotherapy remains a significant hurdle in its treatment. mtDNA, crucial for cellular energy production, is prone to mutations at a higher rate than nuclear DNA. These mutations can accumulate and disrupt cellular function; however, mtDNA mutations induced by chemotherapy in esophageal cancer remain unexplored. We aimed to identify such mutations in esophageal cancer, pre-and post-chemotherapy, and explore the relationship between them and clinicopathological factors associated with chemotherapy resistance. We investigated mtDNA mutations in Human esophageal squamous cell carcinoma (ESCC) cancer cell lines (TE8 and TE11) and patient samples (27 pre-and post-chemotherapy, and 96 post-chemotherapy) using next-generation sequencing. Our analysis revealed a rise in mtDNA mutations following chemotherapy, particularly within the D-loop region. Moreover, mutations in a specific D-loop segment (hypervariable segment 1; HVS1) were associated with lower mtDNA copy number, poorer response to chemotherapy, and decreased five-year survival rates. These findings suggest that HVS1 mutations in mtDNA acquired after chemotherapy may contribute to treatment resistance and poorer clinical outcomes in patients with esophageal cancer. This study sheds light on the mechanisms of chemotherapy resistance and provides valuable insights for future research to overcome this challenge.  \nKeywords Esophageal cancer, Mitochondrial DNA, D-loop, Mutation, MtDNA copy number, Chemotherapy  \nEsophageal cancer is the eighth most common malignant disease and the seventh leading cause of death worldwide1. The standard treatment for advanced esophageal cancer is preoperative chemotherapy followed by surgery2–4however, some patients show resistance to chemotherapy. Therefore, elucidating the underlying mechanisms is necessary to overcome this problem. Although drug resistance towards chemotherapeutic agents is a challenge in clinical esophageal cancer treatment, only a few studies have examined chemotherapy-induced genomic mutations, including their genomic location and frequency of occurrence. One reason for cancer resistance is the mitochondrial dysfunction of cancer cells5. Mitochondria play important roles in maintaining cellular activity, including producing ATP and reactive oxygen species in the cell and regulating apoptosis6–9. Mitochondrial DNA (mtDNA) is a double-stranded circular structure of 16,569 bp with 37 genes encoding 13 proteins, 2 rRNA, and 22 tRNA9–11. A cell contains tens to hundreds of mitochondria, each containing 5–10 copies of mtDNA. However, mtDNA is more easily mutated by environmental changes than nuclear DNA owing to its limited DNA repair mechanism12, 13. Functional abnormalities occur when the ratio of mutant DNA exceedsa certain value; and is referred to as heteroplasmy14. Mutations occurring in mtDNA result in the loss of function of gene products, consequently leading to mitochondrial dysfunction. Aside from protein-coding genes, genetic mutations in non-coding regions such as D-loops play a significant role. Within the context of cancer, mtDNA mutations have been documented to impede the function of the TCA cycle, modify electron transfer systems, elevate oxidative stress production, perturb cellular metabolic pathways, disturb the redox balance, foster apoptosis, enhance treatment resistance, and ultimately contribute to the malignant characteristics of cancer  \n1Department of Gastroenterological Surgery, Graduate School of Medicine,","cbCaigFNn94QJ5cl","https://ap.wps.com/l/cbCaigFNn94QJ5cl","pdf",2149841,11,"English","# Results\n## Changes in mtDNA of ESCC cell lines after cisplatin administration","[{\"question\":\"What is the main research question of the study?\",\"answer\":\"The study investigates whether chemotherapy induces mtDNA mutations in esophageal cancer and whether these changes relate to chemotherapy resistance and clinicopathological factors.\"},{\"question\":\"How were mtDNA mutations assessed?\",\"answer\":\"mtDNA mutations were analyzed in esophageal cancer cell lines and patient samples using next-generation sequencing, including comparison of mutations before and after chemotherapy.\"},{\"question\":\"Which mtDNA region showed the strongest association with resistance-related outcomes?\",\"answer\":\"Mutations increased after chemotherapy, particularly in the D-loop region, and HVS1 D-loop segment mutations were linked to lower mtDNA copy number, poorer response, and decreased five-year survival.\"}]","D-loop mutations in mitochondrial DNA are a risk factor for chemotherapy resistance in esophageal cancer | PDF",1790006192,28]